These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25130147)

  • 1. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients.
    Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M
    Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study.
    Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J;
    J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of CD24 and its expression in Iranian relapsing-remitting multiple sclerosis.
    Kollaee A; Ghaffarpor M; Pourmahmoudian H; Shahbazi M; Zamani M
    Int J Neurosci; 2011 Dec; 121(12):684-90. PubMed ID: 21815873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HLA-DRB1 and HLA-DQB1 alleles are associated with multiple sclerosis disability progression in Slovak population.
    Čierny D; Lehotský J; Kantorová E; Sivák Š; Javor J; Kurča E; Dobrota D; Michalik J
    Neurol Res; 2018 Jul; 40(7):607-614. PubMed ID: 29619906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of the HLA-DRB1 and HLA-DQB1 allele heterogeneity on disease risk and severity in Iranian patients with multiple sclerosis.
    Kollaee A; Ghaffarpor M; Ghlichnia HA; Ghaffari SH; Zamani M
    Int J Immunogenet; 2012 Oct; 39(5):414-22. PubMed ID: 22404765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis.
    Shahbazi M; Abadi JSA; Roshandel D; Koochaki M; Amiri H; Kohansal R; Baghbanian SM; Zamani M
    Indian J Med Res; 2017 Jun; 145(6):746-752. PubMed ID: 29067976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
    Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
    Huang J; Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Sato S; Yamasaki R; Kira J;
    Mult Scler; 2013 Nov; 19(13):1696-703. PubMed ID: 23549433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD24 gene polymorphism is associated with the disease progression and susceptibility to multiple sclerosis in the Iranian population.
    Ronaghi M; Vallian S; Etemadifar M
    Psychiatry Res; 2009 Dec; 170(2-3):271-2. PubMed ID: 19896210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.
    Shawkatová I; Javor J; Párnická Z; Bucová M; Čopíková-Cudráková D; Michalík J; Gmitterová K; Čierny D; Buc M; Ďurmanová V
    Folia Microbiol (Praha); 2017 Jul; 62(4):287-293. PubMed ID: 28130760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis.
    Sayad A
    Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD24 is a genetic modifier for risk and progression of multiple sclerosis.
    Zhou Q; Rammohan K; Lin S; Robinson N; Li O; Liu X; Bai XF; Yin L; Scarberry B; Du P; You M; Guan K; Zheng P; Liu Y
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15041-6. PubMed ID: 14657362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
    Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501.
    Wagner M; Wiśniewski A; Bilińska M; Pokryszko-Dragan A; Nowak I; Kuśnierczyk P; Jasek M
    J Neuroimmunol; 2013 May; 258(1-2):71-6. PubMed ID: 23507476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.
    Apperson ML; Tian Y; Stamova B; Ander BP; Jickling GC; Agius MA; Sharp FR
    J Neuroimmunol; 2013 Apr; 257(1-2):90-6. PubMed ID: 23477965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.
    Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M
    Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.